Viewing Study NCT04796194

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-02-21 @ 1:02 PM
Study NCT ID: NCT04796194
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2021-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
Sponsor: Lytix Biopharma AS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oncolytic peptide View
None LTX-315 View
None Pembrolizumab View
None Intratumoral View
None Melanoma View